TY - JOUR
T1 - Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality
T2 - The osteoporotic fractures in men (MrOS) study
AU - Dominguez, Julie R.
AU - Kestenbaum, Bryan
AU - Chonchol, Michel
AU - Block, Geoffrey
AU - Laughlin, Gail A.
AU - Lewis, Cora E.
AU - Katz, Ronit
AU - Barrett-Connor, Elizabeth
AU - Cummings, Steve
AU - Orwoll, Eric S.
AU - Ix, Joachim H.
N1 - Funding Information:
Support: The MrOS Study is supported by the National Institutes of Arthritis and Musculoskeletal and Skin Diseases, the National Institutes on Aging, the National Center for Research Resources, and the National Institutes of Health Roadmap for Medical Research (grants U01 AR45580 , U01 AR45615 , U01 AR45632 , U01 AR45647 , U01 AR45654 , U01 AR45583 , U01 AG18197 , U01 AG027810 , and UL1 RR024140 ). Dr Dominguez was supported by a training grant from the National Heart, Lung and Blood Institute (NHLBI; T32 HL007261 ). Drs Laughlin, Barrett-Connor, and Ix were supported by a grant from the NHLBI ( R01HL096851 ). Additional support was provided by the Sandra Daugherty Foundation. This material is the result of work supported with resources of the Veterans Affairs San Diego Healthcare System.
PY - 2013/4
Y1 - 2013/4
N2 - Background: Serum phosphorus is associated with cardiovascular disease (CVD) in the general population, but may not comprehensively reflect phosphorus homeostasis. Whether urine phosphorus-creatinine ratio (a marker of intestinal absorption) or urine fractional excretion of phosphorus (FEPi; a marker of urinary phosphorus handling) is associated with risk of mortality or CVD is uncertain. Study Design: Prospective observational study. Setting & Participants: 1,325 community-dwelling men 65 years or older participating in the MrOS Study. Predictor: Serum phosphorus, urine phosphorus-creatinine ratio, and FEPi. Outcomes: All-cause and CVD death. Results: Mean age was 74 ± 6 (SD) years, estimated glomerular filtration rate was 75 ± 16 mL/min/1.73 m2, and serum phosphorus level was 3.2 ± 0.4 mg/dL. During a median follow-up of 9.3 years, there were 364 (120 CVD) deaths. After adjustment for demographics, CVD risk factors, and kidney function, the risks of all-cause death in the highest quartiles of serum phosphorus (≥3.6 mg/dL), urine phosphorus-creatinine ratio (≥0.55), and FEPi (≥18%) were 1.63 (95% CI, 1.23-2.17), 1.22 (95% CI, 0.90-1.65), and 0.88 (95% CI, 0.64-1.23), respectively, compared to the lowest quartiles of each. Results were similar for CVD death. Results also were similar in those with estimated glomerular filtration rate ≥60 and <60 mL/min/1.73 m2. Limitations: Older all-male cohort. Few had advanced chronic kidney disease. Spot urine specimens were used. Conclusions: In community-living older men, higher serum phosphorus concentrations are associated with all-cause and CVD death. In contrast, urine phosphorus-creatinine ratio and FEPi are not. These findings do not support using urine phosphorus-creatinine ratio or FEPi as adjuvant measures to predict risk of mortality or CVD in the general population.
AB - Background: Serum phosphorus is associated with cardiovascular disease (CVD) in the general population, but may not comprehensively reflect phosphorus homeostasis. Whether urine phosphorus-creatinine ratio (a marker of intestinal absorption) or urine fractional excretion of phosphorus (FEPi; a marker of urinary phosphorus handling) is associated with risk of mortality or CVD is uncertain. Study Design: Prospective observational study. Setting & Participants: 1,325 community-dwelling men 65 years or older participating in the MrOS Study. Predictor: Serum phosphorus, urine phosphorus-creatinine ratio, and FEPi. Outcomes: All-cause and CVD death. Results: Mean age was 74 ± 6 (SD) years, estimated glomerular filtration rate was 75 ± 16 mL/min/1.73 m2, and serum phosphorus level was 3.2 ± 0.4 mg/dL. During a median follow-up of 9.3 years, there were 364 (120 CVD) deaths. After adjustment for demographics, CVD risk factors, and kidney function, the risks of all-cause death in the highest quartiles of serum phosphorus (≥3.6 mg/dL), urine phosphorus-creatinine ratio (≥0.55), and FEPi (≥18%) were 1.63 (95% CI, 1.23-2.17), 1.22 (95% CI, 0.90-1.65), and 0.88 (95% CI, 0.64-1.23), respectively, compared to the lowest quartiles of each. Results were similar for CVD death. Results also were similar in those with estimated glomerular filtration rate ≥60 and <60 mL/min/1.73 m2. Limitations: Older all-male cohort. Few had advanced chronic kidney disease. Spot urine specimens were used. Conclusions: In community-living older men, higher serum phosphorus concentrations are associated with all-cause and CVD death. In contrast, urine phosphorus-creatinine ratio and FEPi are not. These findings do not support using urine phosphorus-creatinine ratio or FEPi as adjuvant measures to predict risk of mortality or CVD in the general population.
KW - Phosphorus
KW - cardiovascular disease
KW - geriatrics
KW - kidney disease
KW - mortality
KW - urine phosphorus
UR - http://www.scopus.com/inward/record.url?scp=84875226182&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875226182&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2012.11.033
DO - 10.1053/j.ajkd.2012.11.033
M3 - Article
C2 - 23261120
AN - SCOPUS:84875226182
SN - 0272-6386
VL - 61
SP - 555
EP - 563
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -